DNA Brands, Inc.

DNAX · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$523-$375-$304
Dep. & Amort.$0$0$4
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC$511-$46-$134
Other Non-Cash$0$0$0
Operating Cash Flow-$12-$421-$434
Investing Activities
PP&E Inv.$0$0$0
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow$0$0$0
Financing Activities
Debt Repay.$12$0$0
Stock Issued$0$0$487
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0$356$0
Financing Cash Flow$12$356$487
Forex Effect$0$0$0
Net Chg. in Cash-$0-$65$52
Supplemental Information
Beg. Cash$0$67$15
End Cash$0$2$67
Free Cash Flow-$12-$421-$434
DNA Brands, Inc. (DNAX) Financial Statements & Key Stats | AlphaPilot